First Eagle Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
First Eagle Investment Management's PFE Position: Q1 2018 in Review
First Eagle Investment Management sold out of Pfizer (PFE) in Q1 2018, closing a stake of 83,330 shares — an estimated $2.86M sold.
First Eagle Investment Management first reported a position in PFE in Q2 2013 and held it in 19 quarters. The position peaked at $312M in Q4 2013. 2,231 funds tracked by Wall St. Rank hold PFE as of Q1 2018.
- First Eagle Investment Management reported no remaining Pfizer position as of Q1 2018 after selling out during the quarter.
- First Eagle Investment Management sold 83,330 Pfizer shares in Q1 2018, an estimated $2.86M.
- First Eagle Investment Management first reported a position in Pfizer in Q2 2013 and held it in 19 quarters.
- First Eagle Investment Management's Pfizer position peaked at $312M in Q4 2013.
- 2,231 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.
Based on First Eagle Investment Management's 13F filing for Q1 2018, filed 4 May 2018.